COMMUNIQUÉS West-GlobeNewswire

Helix BioPharma Corp. Completes Fourth Dosing Cohort and Initiates Enrollment of the Next Cohort in U.S. Combination Treatment Study of Its Lung Cancer Drug Candidate L-DOS47
25/07/2018
RICHMOND HILL, Ontario, July 25, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FSE:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Myriad Announces Publication of IMPACT Study in Journal of Psychiatric Research
25/07/2018
Results Show that Primary Care Physicians Obtained Improved Outcomes for Patients with Depression When Medication Selection Is Guided by the GeneSight® Test SALT LAKE CITY, July 25, 2018 (GLOBE NEWSWIRE) -- Myriad [...]
Sarepta Therapeutics Announces that Phase 1/2a Duchenne Muscular Dystrophy (DMD) Micro-Dystrophin Gene Therapy Trial Placed on Clinical Hold Due to an Out-of-Specification Production Lot; No Observed Safety Events
25/07/2018
-- Out-of-specification lot resulted from the presence of trace levels of DNA fragment in research-grade raw material plasmid sourced from third-party manufacturer -- -- Fragment fully characterized; preliminary testing [...]
Eisai and Biogen Announce Detailed Results of Phase II Clinical Study of BAN2401 in Early Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2018
25/07/2018
TOKYO and CAMBRIDGE, Mass., July 25, 2018 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq:BIIB) (Headquarters: Cambridge, Massachusetts, United States, CEO: [...]
Savara Announces Proposed Public Offering of Common Stock
25/07/2018
AUSTIN, Texas, July 25, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (Nasdaq:SVRA), an orphan lung disease company, today announced that it intends to offer and sell, subject to market conditions, shares of its common stock in [...]
Histogenics Corporation to Present at Canaccord Genuity’s 38th Annual Growth Conference
25/07/2018
WALTHAM, Mass., July 25, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]
The Cooper Companies Announces Release Date for Third Quarter 2018
25/07/2018
PLEASANTON, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced it will release third quarter 2018 financial results on Thursday, August 30, 2018, at 4:15 PM ET. Following the [...]
Supernus to Host Second Quarter 2018 Earnings Conference Call
25/07/2018
ROCKVILLE, Md., July 25, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]
BioTelemetry, Inc. Reports Second Quarter 2018 Financial Results
25/07/2018
Company Delivers Record Results Raises Full-Year Guidance MALVERN, Pa., July 25, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote and wireless medical technology company focused on the [...]
EyePoint Pharmaceuticals Announces Presentation of Data Highlighting YUTIQ™ for Posterior Segment Uveitis at the 36th Annual Scientific Meeting of the American Society of Retina Specialists
25/07/2018
YUTIQ ™ delivers positive twelve month efficacy vs sham with reduced rates of recurrence and reduced use of rescue therapies in patients with noninfectious posterior segment uveitis NDA currently under review by FDA; [...]
Conatus Pharmaceuticals to Report Second Quarter 2018 Financial Results
25/07/2018
SAN DIEGO , July 25, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced that it will report financial results for the second quarter ended June 30, 2018, after the market close on [...]
Chembio Diagnostics to Report Second Quarter 2018 Financial Results on August 8, 2018
25/07/2018
MEDFORD, N.Y., July 25, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic testing, announced today that it will release financial results for the second [...]
Coherus BioSciences Announces New Employment Inducement Grants
25/07/2018
REDWOOD CITY, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that effective July 19, 2018, the compensation committee of the company’s board of directors granted 11 [...]
GenMark Diagnostics to Present at the Canaccord Genuity 38th Annual Growth Conference
25/07/2018
CARLSBAD, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief [...]
Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares
25/07/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa., July 25, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV) today announced that it has commenced an underwritten public offering of $50.0 million of ordinary [...]
Savara Provides Positive Update on Development and Commercial Preparations of Molgradex, Including Expansion into NTM In CF
25/07/2018
Acquires assets of Cardeas and Announces Appointment of A. Bruce Montgomery, M.D., As Strategic Advisor AUSTIN, Texas, July 25, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (Nasdaq:SVRA), an orphan lung disease company, today [...]
Align Technology Expands Operations in Costa Rica With New Facilities to Support Continued Long-Term Growth
25/07/2018
Grand Opening Celebration Attended by Costa Rican President Carlos Alvarado Quesada SAN JOSE, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN), announced today that it hosted a grand [...]
Align Technology Announces Second Quarter 2018 Financial Results
25/07/2018
Q2 revenues up 37.5% year-over-year to a record $490.3 million, and diluted EPS of $1.30 Q2 operating income up 46.8% year-over-year to $122.7 million, operating margin of 25.0% Q2 total Invisalign case shipments up 30. [...]
Correction: Rubicon Organics Capitalizes on the Organic Movement -- CFN Media
25/07/2018
In a release dated June 17, 2018, it was mistakenly stated that Rubicon Organics has operations in Washington and Colorado; instead, Rubicon Organics has operations in Washington and California. The corrected release [...]

Pages